Released date: February 18, 2017
AI for Selection of Combination Therapies
Released date: September 21, 2016
On World Alzheimer’s Day, Does the Global Drug Landscape Offer Potential in the Treatment of Alzheimer’s Disease?
Released date: September 15, 2016
Oh! It’ll be you then…Hotspot Goes Biosimilar!
Released date: September 12, 2016
Hot off the Press! Roche Makes Waves as the New Player on the Block for NSCLC!
Released date: September 1, 2016
Today’s Edition of PharmGPS® Insights Tackles COPD! Are we Ever to See the Emergence of a Disease Modifying Therapy?
Released date: August 10, 2016
BMS’s Opdivo® Placed in a Hotspot Over Latest Clinical Results. Is There Light at the End of the Tunnel?
Released date: August 9, 2016
Your Latest Edition of PharmGPS® Insights is Here. A 60yr Wait for Benlysta® but GSK is About to Feel the Heat!
Released date: July 7, 2016
From Doomed to Deemed: Brodalumab Continues Its Long Fateful Journey
Leo Pharma, an established company in psoriasis treatment, took analysts by surprise when it obtained the development and commercialization rights in Europe for brodalumab, an IL-17R antagonist. Valeant Pharmaceuticals had previously acquired broad worldwide rights to brodalumab from AstraZeneca in Read More
Released date: June 28, 2016
PEGylated Interleukin-10: A New Approach to Promote Anti-Tumor Immunity